NM_003052.5:c.1204G>C
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PP3_Moderate
The NM_003052.5(SLC34A1):c.1204G>C(p.Gly402Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000235 in 1,614,260 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_003052.5 missense
Scores
Clinical Significance
Conservation
Publications
- hypercalcemia, infantile, 2Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen
- dominant hypophosphatemia with nephrolithiasis or osteoporosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- primary Fanconi syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- autosomal recessive infantile hypercalcemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- hypophosphatemic nephrolithiasis/osteoporosis 1Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- Fanconi renotubular syndrome 2Inheritance: AR Classification: LIMITED, NO_KNOWN Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC34A1 | NM_003052.5 | c.1204G>C | p.Gly402Arg | missense_variant | Exon 11 of 13 | ENST00000324417.6 | NP_003043.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC34A1 | ENST00000324417.6 | c.1204G>C | p.Gly402Arg | missense_variant | Exon 11 of 13 | 1 | NM_003052.5 | ENSP00000321424.4 | ||
SLC34A1 | ENST00000507685.5 | n.1495G>C | non_coding_transcript_exon_variant | Exon 9 of 10 | 2 | |||||
SLC34A1 | ENST00000513614.1 | n.938G>C | non_coding_transcript_exon_variant | Exon 3 of 4 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000177 AC: 27AN: 152274Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000278 AC: 7AN: 251432 AF XY: 0.0000221 show subpopulations
GnomAD4 exome AF: 0.00000752 AC: 11AN: 1461868Hom.: 0 Cov.: 32 AF XY: 0.00000550 AC XY: 4AN XY: 727234 show subpopulations
GnomAD4 genome AF: 0.000177 AC: 27AN: 152392Hom.: 0 Cov.: 32 AF XY: 0.000242 AC XY: 18AN XY: 74532 show subpopulations
ClinVar
Submissions by phenotype
not provided Uncertain:3
Identified as a single heterozygous variant in a patient with infantile hypercalcemia; the variant was noted to be paternally inherited but clinical information was limited (PMID: 29959532); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 31589614, 28893421, 29959532) -
- -
This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 402 of the SLC34A1 protein (p.Gly402Arg). This variant is present in population databases (rs376131751, gnomAD 0.07%). This missense change has been observed in individual(s) with clinical features of infantile hypercalcemia (PMID: 28893421, 29959532). ClinVar contains an entry for this variant (Variation ID: 548678). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Nephrocalcinosis;C0392525:Nephrolithiasis Pathogenic:1
- -
SLC34A1-related disorder Pathogenic:1
The SLC34A1 c.1204G>C variant is predicted to result in the amino acid substitution p.Gly402Arg. This variant has been reported to be causative for idiopathic infantile hypercalcemia (Hureaux et al. 2018. PubMed ID: 29959532; Daga. 2018. PubMed ID: 28893421). This variant is reported in 0.068% of alleles in individuals of African descent in gnomAD. This variant is interpreted as likely pathogenic. -
Hypophosphatemic nephrolithiasis/osteoporosis 1;C3150652:Fanconi renotubular syndrome 2;C4310473:Hypercalcemia, infantile, 2 Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at